Solcitinib
Solcitinib (GSK2586184, GLPG0778) is a JAK1 inhibitor. Solcitinib may be potentially used for the treatment of psoriasis, ulcerative colitis, and systemic lupus erythematosus.
| Catalog Number | T3620 |
| Alternative Name(s) | GLPG-0778 , GSK-2586184 |
| Research Area | Chromatin/Epigenetic|||Stem Cells|||JAK/STAT signaling|||Angiogenesis |
| Molecular Formula | C22H23N5O2 |
| CAS# | 1206163-45-2 |
| SMILES | O=C(C=1C=CC(=CC1)C2=CC=CC3=NC(=NN32)NC(=O)C4CC4)N5CC(C)(C)C5 |
| Size | 25 mg |
| Supplier Page | https://www.targetmol.com/compound/Solcitinib |
| Additional Information | https://www.targetmol.com/datasheet/T3620 |
